Principal Scientific Manager, IMI
Ann Martin is responsible for the Knowledge Management projects at the Innovative Medicines Initiative (IMI) and Knowledge management aspects of the IMI collaborations. Between 1997 and 2009, Ann Martin held various management positions in the pharmaceutical industry as Global Head of Biostatistics for UCB Pharma (1997-2001), Global Section Head of Statistical Programming for Novartis (2001-2005) and Global Head Statistical Programming Operations, Standards and CDISC Implementation at UCB Pharma (2005-2009), giving her a broad knowledge on drug development and extensive international experience with Europe, the US and India. Between 1987 and 1997, she worked for Bristol-Myers-Squibb both as a Junior and Project Biostatistician in multiple therapeutic areas, following a short period as research assistant at the University of Lancaster (1985-1987). Ann Martin is a Chartered Statistician and holds a Masters degree in Sociology and Statistics from the London School of Economics and Political Science, UK.